Pfizer INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
PFE
Pfizer INCForm 4: Pfizer CEO Buys Shares
Albert Bourla, Chairman & CEO and a Director of Pfizer Inc, purchased 38,000 shares of common stock on August 12, 2026 for $26.34 per share.
NYSE
PFE
Pfizer INCForm 4: Pfizer Executive Sells Shares
Jennifer B. Damico, SVP & Controller of Pfizer Inc, sold 3,278 shares of common stock on August 5, 2026 for $25.40 per share.
NYSE
PFE
Pfizer INCForm 4: Pfizer Director Buys Shares
Ronald E Blaylock, a Director of Pfizer Inc, purchased 39,231 shares of common stock on August 5, 2026 for $25.46 per share.
NYSE
PFE
Pfizer INCForm 4: Pfizer CEO Receives Stock Grant
Albert Bourla, Chairman & CEO and a Director of Pfizer Inc, received 24 shares of common stock on July 31, 2026.
NYSE
PFE
Pfizer INCForm 4: Pfizer CEO Receives Stock Grant
Albert Bourla, Chairman & CEO and a Director of Pfizer Inc, received 24 shares of common stock on July 15, 2026.
NYSE
PFE
Pfizer INCForm 4: Pfizer CEO Receives Stock Grant
Albert Bourla, Chairman & CEO and a Director of Pfizer Inc, received 84 shares of common stock on July 9, 2026.
NYSE
PFE
Pfizer INCPfizer Chairman & CEO Albert Bourla acquired 25 phantom stock units under a deferred compensation plan on June 30, 2026.
NYSE
PFE
Pfizer INCPfizer Inc. director Mortimer J. Buckley has reported transactions involving phantom stock units, settling deferred compensation.
NYSE
PFE
Pfizer INCPfizer Inc. Director Joseph Echevarria acquired 1,904.076 phantom stock units on June 26, 2026, as part of a deferred compensation plan.
NYSE
PFE
Pfizer INCPfizer Inc. director Shantanu Narayen acquired 2,058.46 phantom stock units, representing deferred compensation.
NYSE
PFE
Pfizer INCPfizer Inc. director James C. Smith acquired 1,852.614 phantom stock units, representing deferred compensation, on June 26, 2026.
NYSE
PFE
Pfizer INCPfizer Inc. director James Quincey acquired 1,595.307 phantom stock units, representing deferred compensation.
NYSE
PFE
Pfizer INCPfizer Inc. director Cyrus Taraporevala reported a transaction involving phantom stock units, settled in common stock.
NYSE
PFE
Pfizer INCPfizer Chairman & CEO Albert Bourla acquired 23 phantom stock units under a deferred compensation plan on June 15, 2026.
NYSE
PFE
Pfizer INCPfizer's SVP & Controller, Jennifer B. Damico, reported a pre-planned sale of 2,000 shares of common stock scheduled for June 2026.
NYSE
PFE
Pfizer INCPfizer Chairman and CEO Albert Bourla acquired 23 phantom stock units through the company's deferred compensation plan.
NYSE
PFE
Pfizer INCPfizer Chairman & CEO Albert Bourla acquired 24 phantom stock units under a deferred compensation plan on May 15, 2026.
NYSE
PFE
Pfizer INCPfizer Chairman and CEO Albert Bourla has reported transactions involving phantom stock units acquired under a company plan.
NYSE
PFE
Pfizer INCPfizer Inc. director Scott Gottlieb was granted 7,686.539 phantom stock units as part of the company's deferred compensation plan for non-employee directors.
NYSE
PFE
Pfizer INCPfizer Inc. director Suzanne Nora Johnson acquired 7,686.539 phantom stock units as part of deferred director compensation.
NYSE
PFE
Pfizer INCPfizer Inc. director Dan R. Littman was granted 7,686.539 phantom stock units as part of the company's deferred compensation plan.
NYSE
PFE
Pfizer INCPfizer Inc. director Ronald E. Blaylock was granted 7,686.539 phantom stock units as part of deferred director compensation.
NYSE
PFE
Pfizer INCPfizer Inc. Director Mortimer J. Buckley was granted 7,686.539 phantom stock units as part of deferred director compensation.
NYSE
PFE
Pfizer INCPfizer Inc. director Susan Desmond-Hellmann was granted 7,686.539 phantom stock units as part of deferred director compensation.
NYSE
PFE
Pfizer INCPfizer Inc. director Joseph Echevarria was granted 7,686.539 phantom stock units as part of deferred director compensation.
NYSE
PFE
Pfizer INCPfizer Director Shantanu Narayen acquired 7,686.539 phantom stock units as part of deferred director compensation.
NYSE
PFE
Pfizer INCPfizer Inc. director James Quincey was granted 7,686.539 phantom stock units as part of the company's deferred compensation plan for non-employee directors.
NYSE
PFE
Pfizer INCPfizer Inc. director James C. Smith was granted 7,686.539 phantom stock units as part of the company's deferred compensation plan for non-employee directors.
NYSE
PFE
Pfizer INCPfizer Inc. director Cyrus Taraporevala was granted 7,686.539 phantom stock units as part of the company's deferred compensation plan.
NYSE
PFE
Pfizer INCPfizer Chairman and CEO Albert Bourla acquired 22 phantom stock units through the company's deferred compensation plan.